The VMD hosted a very successful stakeholder open meeting which this year was combined with the Veterinary Products Committee (VPC) and the pharmaceutical industry information event. The day brought together a wide range of stakeholders from the pharmaceutical Industry, VPC members, wholesalers, consultants, the charity sector and the media.
Over 70 people attended the event which was opened by Professor Pete Borriello (CEO) and Abi Seager (Director of Authorisations) to hear the latest information about:
- the work of the VPC from its chair – Malcolm Bennett
- the VMD’s international work
- antimicrobial resistance
- animal use in Quality Control testing of Immunological Veterinary Medicinal Products
- the VMD’s joint inspections with the Medicines and Healthcare products Regulatory Agency
- Brexit’s implications for the supply and regulation of veterinary medicines
- the relevance of European regulations
David Catlow – a VMD Non-Executive Director and Clinical Director of the Blue Cross – gave a keynote speech on ‘Opportunity in a Changing Landscape’ highlighting the VMD’s excellent work to ensure continued effective medicines regulation after Brexit.
There were two new elements to the event. Over lunch attendees enjoyed displays and demonstrations from the VMD teams on:
- VMD’s Digital Services
- Adverse Event reporting
- Brexit readiness
- Special Imports
There was also a drop-in ‘Ask an Assessor’ area where scientific assessors were on hand to answer questions about any aspect of the safety, quality and efficacy assessment processes for marketing authorisations applications for veterinary medicines.
The VMD has already received very positive feedback on the event, in particular its innovative format and content.
The event is part of the VMD’s ongoing work to engage with its stakeholders on medicines regulation.